TRUEHN HEALTH INC PERPETUAL PREFERRED STOCK TRUEHN HEALTH INC ´s BSC Perpetual Preferred Stock (THIBSC) and POS Perpetual Preferred Stock (THIPOS) are preferred stock offerings launched early this year to raise capital, primarily for HEARTASSET acquisitions and the HEARTASSET TREASURY COMPANY strategy of TRUEHN HEALTH INC. THIBSC offers an 8,88% dividend payable in cash or TRUEHN HEALTH INC stock and is convertible into TRUEHN HEALTH INC’s common stock, whereas THIPOS, is non-convertible and prioritizes stability for fixed-income investors. +++ FOR MORE INFORMATION ABOUT THIBSC &THIPOS - info@tgg.capital +++

The TRUEHN HEALTH INC BOND 2025 shall bear interest at a rate of Five Point Eight Three Percent [5.83%] per annum, payable annually, and shall mature on 09.09.2031. The TRUEHN HEALTH INC BOND 2025 Issuer covenants to: Maintain its corporate existence. Comply with applicable laws and regulations. Provide the Bondholder with annual financial statements. The TRUEHN HEALTH INC BOND 2025 Issuer shall pay the principal sum of the Bonds to the Bondholder on the Maturity Date. Interest on the Bonds shall be paid in arrears on the 30th of December [30.12]. +++ FOR MORE INFORMATION ABOUT THIB25 - info@tgg.capital

TRUEHN HEALTH INC announced today that it intends to offer, subject to market conditions and other factors, 1 billion aggregate principal amounts of 0,00% Convertible Senior Notes due 2031 (the „notes") in a private offering (the "offering") to persons reasonable believed to be qualified institutional buyers. TRUEHN HEALTH INC also intends to grant the initial purchasers of the notes an option to purchase, within a 33-days period, beginning on, and including, the date on which the notes are first issued, up to an additional 385 million aggregate principal number of notes. The notes will be general unsecured obligations of TRUEHN HEALTH INC, will not bear regular interest and the principal amount will not accrete. The notes will mature on 09. September 2031, unless earlier converted, redeemed or repurchased. Upon conversion, TRUEHN HEALTH INC will pay cash. The initial conversion rate, repurchase or redemption rights and other terms of the notes will be determined at the time of pricing of the offering. TRUEHN HEALTH INC expects to use the net proceeds from the offering for general corporate purposes, including the acquisition of HEARTASSETS in a manner consistent with the Truehn Standard Investment Policy. +++ FOR MORE INFORMATION ABOUT THIN25 - info@tgg.capital